Log in with your email address username.


[Comment] Risks during pregnancy in women with epilepsy

Since 2000, a great deal of new information has become available about pregnancy outcomes in women with epilepsy. Most of this information has been related to the risks of major congenital malformations and cognitive behavioural deficits in children of women with epilepsy who had fetal antiepileptic drug exposure.1–3 These studies have emphasised the risks of major congenital malformations, cognitive impairment, and autistic spectrum disorder for children exposed in utero to valproate (9·3% at 1 year of age).